Back
Franklin Responsibly Sourced Gold ETF Vs. Bright Minds Biosciences, Inc. Industry Stock Comparison
Buy
73
FGDL
Franklin Responsibly Sourced Gold ETF
Last Price:
$57.87
Seasonality Move:
5.72%
Sell
45
DRUG
Bright Minds Biosciences, Inc.
Last Price:
$83.03
Seasonality Move:
-32.16%
Buy
73
Franklin Responsibly Sourced Gold ETF (FGDL)
is a Buy
Is Franklin Responsibly Sourced Gold ETF a Buy, Sell or Hold?
-
The current Franklin Responsibly Sourced Gold ETF [FGDL] share price is $57.89. The Score for FGDL is 73, which is 46% above its historic median score of 50, and infers lower risk than normal.
-
FGDL is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Bright Minds Biosciences, Inc. (DRUG)
is a Sell
Is Bright Minds Biosciences, Inc. a Buy, Sell or Hold?
-
The current Bright Minds Biosciences, Inc. [DRUG] share price is $78.88. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FGDL Stock Price Chart
What is Franklin Responsibly Sourced Gold ETF's stock price today?
-
The Franklin Responsibly Sourced Gold ETF share price today is $57.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FGDL is experiencing slight selling pressure.
DRUG Stock Price Chart
What is Bright Minds Biosciences, Inc.'s stock price today?
-
The Bright Minds Biosciences, Inc. share price today is $78.88The current trend is moderately bullish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
FGDL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.87 | Buy |
| Relative Strength Index (14 RSI): | 68.64 | Buy |
| Chaikin Money Flow: | -8434 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.85 - 57.15) | Buy |
| Bollinger Bands (100): | (46.95 - 55.91) | Buy |
DRUG Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.94 | Buy |
| Relative Strength Index (14 RSI): | 54.75 | Buy |
| Chaikin Money Flow: | -145421 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.39 - 83.51) | Buy |
| Bollinger Bands (100): | (41.65 - 69.37) | Buy |
FGDL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.25 | Buy |
| 20-day SMA: | 56.35 | Buy |
| 50-day SMA: | 55.25 | Buy |
| 200-day SMA: | 47.4 | Buy |
| 8-day EMA: | 57.33 | Buy |
| 20-day EMA: | 56.48 | Buy |
| 50-day EMA: | 54.8 | Buy |
| 200-day EMA: | 48.13 | Buy |
DRUG Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 85.2 | Sell |
| 20-day SMA: | 75.43 | Buy |
| 50-day SMA: | 66.05 | Buy |
| 200-day SMA: | 43.03 | Buy |
| 8-day EMA: | 83.79 | Sell |
| 20-day EMA: | 77.26 | Buy |
| 50-day EMA: | 67.4 | Buy |
| 200-day EMA: | 47.62 | Buy |
Franklin Responsibly Sourced Gold ETF Earnings Growth & FGDL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Bright Minds Biosciences, Inc. Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.89 per share, and a decrease next year of $3.34 per share.
Franklin Responsibly Sourced Gold ETF Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bright Minds Biosciences, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||